Donate-Correa, Javier
Ferri, Carla M.
Mora-Fernández, Carmen
Pérez-Delgado, Nayra
González-Luis, Ainhoa
Navarro-González, Juan F.
Funding for this research was provided by:
Instituto de Salud Carlos III (PI21/01037, PI16/00024, PI19/00035, RD16/0009/0022, CP20/00122, FI22/00213, PI21/01037, PI16/00024, PI19/00035, RD16/0009/0022, CP20/00122, FI22/00213, PI21/01037, PI16/00024, PI19/00035, RD16/0009/0022, CP20/00122, FI22/00213, PI21/01037, PI16/00024, PI19/00035, RD16/0009/0022, CP20/00122, FI22/00213, PI21/01037, PI16/00024, PI19/00035, RD16/0009/0022, CP20/00122, FI22/00213)
Fundación Canaria Instituto de Investigación Sanitaria de Canarias (PIFIISC21/08)
Agencia Canaria de Investigación, Innovación y Sociedad de la Información (TESIS2018010110)
Article History
Received: 18 June 2024
Accepted: 6 August 2024
First Online: 24 August 2024
Declarations
:
: The trial was approved by the Institutional Review Board at the Hospital Universitario Nuestra Señora de Candelaria. The study protocol code is PTF-AA-TR-2009 and the trial was registered on the European Union Drug Regulating Authorities Clinical Trials (EudraCT #2009–016595– 77). The validation date was 2010-03-09.
: All authors approve the manuscript and give their consent for submission and publication.
: The authors declare no competing interests.